Efficacy evaluation on intestinal microbiome metabolites and metabolic disease related factors after consumption of gochujang in obesity

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006899

Enrollment

Registered

2022-01-06

Start date

2021-11-30

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The purpose of this study is to investigate the effect of conventional gochujang intake on obese people by evaluating body measurement and body composition, blood biochemical test

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 23 kg/m²=BMI(Body mass index) or PBF(Percent body fat) is over 25% as male, over 30% as female. 2) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Participants who have a change of weight over 10% within 3 months prior to the screening examination 2) Participants who have an obesity surgery within 1 year 3) Patients with a clinically significant disease requiring treatment (i.e., cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.) 4) Participants who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

Measure	Time frame
Body fat mass;changes of intestinal microbiome	—

Secondary

Measure	Time frame
Fat free mass;Lipid metabolism index;Obesity hormone index	—

Countries

Korea, Republic of

Contacts

Public ContactA Lum Han

Wonkwang University Hospital

qibosarang@naver.com+82-63-859-2543

Outcome results